Genedata Overview
Pro stress-test →Genedata is the leading global provider of enterprise software solutions that digitalize data-rich and complex biopharmaceutical R&D processes to enable AI approaches for precision medicines. Over 200 companies rely on the Genedata Biopharma platform, including all top-25 biopharma companies worldwide, making it the global market leader. Genedata joined Danaher in 2024.
Strategic Profile
Pro stress-test →Genedata software helps biopharmaceutical organizations optimize workflows, increase research automation, improve experimental data quality, and maximize ROI in R&D expenditure. As a 100% privately held subsidiary of Danaher, Genedata combines deep scientific expertise with data analytics and AI to serve the world's largest pharmaceutical and biotech companies across the drug discovery-to-clinic continuum.
Competitive Landscape
Pro stress-test →Genedata operates in the enterprise biopharma software space alongside vendors offering ELN (electronic laboratory notebooks), LIMS (laboratory information management), and specialized analytics tools. Direct competitors include Benchling (biotech R&D cloud platform), LabWare (LIMS), and Thermo Fisher Scientific's informatics offerings. Genedata's differentiation lies in its end-to-end coverage from discovery through manufacturing, deep biopharma domain expertise, and AI/data analytics integration.
Industry Context
Genedata operates in Biopharmaceutical R&D software platforms.
Key facts
Founded: 1997 · Headquarters: Basel, Switzerland · Employees: ~500 · Revenue: Estimated $150M–$250M (private subsidiary of Danaher as of 2024) · Market cap: N/A